Akero Therapeutics Inc
(AKRO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -222,796 | -141,230 | -70,725 | -252,060 | -182,036 |
| Depreciation Amortization | -7,209 | -4,959 | -2,285 | -12,493 | -9,670 |
| Accounts payable and accrued liabilities | 11,379 | 4,203 | 1,811 | 2,008 | 18,118 |
| Other Working Capital | 18,258 | 12,074 | -3,606 | 2,998 | 4,387 |
| Other Operating Activity | 17,287 | 14,002 | 7,141 | 29,440 | 6,184 |
| Operating Cash Flow | $-183,081 | $-115,910 | $-67,664 | $-230,107 | $-163,017 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -346,062 | -402,843 | -482,183 | -108,709 | -123,981 |
| Other Investing Activity | 0 | 0 | 0 | -999 | -999 |
| Investing Cash Flow | $-346,062 | $-402,843 | $-482,183 | $-109,708 | $-124,980 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 10,000 | 10,000 |
| Debt Repayment | -37,398 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 402,911 | 399,540 | 396,107 | 436,690 | 360,670 |
| Other Financing Activity | -576 | -576 | -576 | -844 | -815 |
| Financing Cash Flow | $364,937 | $398,964 | $395,531 | $445,846 | $369,855 |
| Beginning Cash Position | 340,238 | 340,238 | 340,238 | 234,207 | 234,207 |
| End Cash Position | 176,032 | 220,449 | 185,922 | 340,238 | 316,065 |
| Net Cash Flow | $-164,206 | $-119,789 | $-154,316 | $106,031 | $81,858 |
| Free Cash Flow | |||||
| Operating Cash Flow | -183,081 | -115,910 | -67,664 | -230,107 | -163,017 |
| Free Cash Flow | -183,081 | -115,910 | -67,664 | -230,107 | -163,017 |